Evidence map›Paper›PMID 29118027›Full record

ArticleAmerican journal of physiology. Cell physiology2018

Heterogeneity of signal transduction by Na-K-ATPase α-isoforms: role of Src interaction.

Hui Yu, Xiaoyu Cui, Jue Zhang, Joe X Xie, Moumita Banerjee, Sandrine V Pierre, Zijian Xie

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Role of Na/K-ATPase α1 caveolin-binding motif in adipogenesis.American journal of physiology. Cell physiology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. NaMolecules (Basel, Switzerland) · 2021
    Review
  13. Article
  14. The αScientific reports · 2020
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hui YuDepartment of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaoyu CuiMarshall Institute for Interdisciplinary Research, Marshall University, Huntington, West Virginia.
Jue ZhangMarshall Institute for Interdisciplinary Research, Marshall University, Huntington, West Virginia.
Joe X XieDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Moumita BanerjeeMarshall Institute for Interdisciplinary Research, Marshall University, Huntington, West Virginia.
Sandrine V PierreMarshall Institute for Interdisciplinary Research, Marshall University, Huntington, West Virginia.
Zijian XieMarshall Institute for Interdisciplinary Research, Marshall University, Huntington, West Virginia.
Marshall University · USEmory University · USUnion Hospital · CN

Funding

Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac DiseasesR01HL109015 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SHAPIRO, JOSEPH ISAAC, XIE, ZIJIAN · 2011 to 2014
$2.2M
NHLBI NIH HHS R01 HL109015
6 · The paper itself

Abstract

Of the four Na-K-ATPase α-isoforms, the ubiquitous α1 Na-K-ATPase possesses both ion transport and Src-dependent signaling functions. Mechanistically, we have identified two putative pairs of domain interactions between α1 Na-K-ATPase and Src that are critical for α1 signaling function. Our subsequent report that α2 Na-K-ATPase lacks these putative Src-binding sites and fails to carry on Src-dependent signaling further supported our proposed model of direct interaction between α1 Na-K-ATPase and Src but fell short of providing evidence for a causative role. This hypothesis was specifically tested here by introducing key residues of the two putative Src-interacting domains present on α1 but not α2 sequence into the α2 polypeptide, generating stable cell lines expressing this mutant, and comparing its signaling properties to those of α2-expressing cells. The mutant α2 was fully functional as a Na-K-ATPase. In contrast to wild-type α2, the mutant gained α1-like signaling function, capable of Src interaction and regulation. Consistently, the expression of mutant α2 redistributed Src into caveolin-1-enriched fractions and allowed ouabain to activate Src-mediated signaling cascades, unlike wild-type α2 cells. Finally, mutant α2 cells exhibited a growth phenotype similar to that of the α1 cells and proliferated much faster than wild-type α2 cells. These findings reveal the structural requirements for the Na-K-ATPase to function as a Src-dependent receptor and provide strong evidence of isoform-specific Src interaction involving the identified key amino acids. The sequences surrounding the putative Src-binding sites in α2 are highly conserved across species, suggesting that the lack of Src binding may play a physiologically important and isoform-specific role.

Indexed as

AnimalsCaveolin 1Enzyme InhibitorsEpithelial CellsExtracellular Signal-Regulated MAP KinasesKidneyLLC-PK1 CellsMutationOuabainProtein BindingProtein ConformationProtein Interaction Domains and MotifsSignal TransductionSodium-Potassium-Exchanging ATPasesrc-Family KinasesStructure-Activity RelationshipAtp1a1 protein, ratAtp1a2 protein, ratCaveolin 1Enzyme InhibitorsExtracellular Signal-Regulated MAP KinasesOuabainSodium-Potassium-Exchanging ATPasesrc-Family Kinasesextracellular signal-regulated kinase (ERK)ouabainsignal transductionSrcα1/2 Na-K-ATPase

Identifiers

PMID29118027
PMCPMC5866435
OpenAlexW2768054630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.